Arvinas (ARVN) EBT Margin (2017 - 2026)
Arvinas (ARVN) recorded EBT Margin of -10740.00% in Q3 2026, down 10656.95 percentage points from -83.05% a year earlier and down 10807.92 percentage points from the prior quarter.
Arvinas (ARVN) EBT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Arvinas' EBT Margin came in at -3.20% as of Sep 30, 2026, up 15.60 percentage points year-over-year; for FY2025, it was -30.65%, up 44.63 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +414.13 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -75.28% in FY2024 (+388.28 pp), -463.57% in FY2023 (-272.55 pp), -191.02% in FY2022 (+152.45 pp) and -343.47% in FY2021 (+101.32 pp).
- The Q3 2026 figure is the lowest quarterly EBT Margin in data going back to Q1 2017.
- On a year-over-year basis, EBT Margin rose in two of the last seven quarters, with an average year-over-year change of -1614.86 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 724.90 percentage points in Q2 2022, against a drop of 10656.95 percentage points in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 67.92% (Q2 2026), -368.59% (Q1 2026) and -707.37% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | -10,740.00% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10,740.00% |
| Jun 30, 2026 | 67.92% |
| Mar 31, 2026 | -368.59% |
| Dec 31, 2025 | -707.37% |
| Sep 30, 2025 | -83.05% |
| Jun 30, 2025 | -274.55% |
| Mar 31, 2025 | 44.01% |
| Dec 31, 2024 | -76.86% |
| Sep 30, 2024 | -47.46% |
| Jun 30, 2024 | -45.75% |
| Mar 31, 2024 | -273.91% |
| Sep 30, 2023 | -184.68% |
| Jun 30, 2023 | -120.37% |
| Mar 31, 2023 | -249.85% |
| Dec 31, 2022 | -183.33% |
| Sep 30, 2022 | -184.04% |
| Jun 30, 2022 | -189.64% |
| Mar 31, 2022 | -213.58% |
| Dec 31, 2021 | -138.86% |
| Sep 30, 2021 | -503.23% |
Arvinas EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();